about
Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facilityA cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, CanadaA cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada.Should North America's first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?Peer-engagement and its role in reducing the risky behavior among crack and methamphetamine smokers of the Downtown Eastside community of Vancouver, Canada."SALOME gave my dignity back": the role of randomized heroin trials in transforming lives in the Downtown Eastside of Vancouver, Canada.Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs.The lessons learned from the fentanyl overdose crises in British Columbia, Canada.Missing the trends in the fentanyl overdose crisis: The need for immediate intervention in small and rural communities.The synthetic opioid epidemic and the need for mental health support for first responders who intervene in overdose casesScience versus politics: the need for supervised injection facilities in Montreal, CanadaThe Opioid Epidemic: Task-Shifting in Health Care and the Case for Access to Harm Reduction for People Who Use DrugsA call for action for mental health intervention and support for refugees who escape internal conflicts or warTwo decades of activism, social justice, and public health civil disobedience: VANDUCOVID-19 and people who use drugs: a call for actionCOVID-19 and sex workers: human rights, the struggle for safety and minimum incomeRefugees, asylum seekers and COVID-19: Canada needs to do more to protect at-risk refugees during the current pandemic
P50
Q33717043-F2804EE5-A76E-4D5B-96EF-61343934E550Q34009387-D5B55B35-4590-4092-96AD-569C491E632BQ34611579-41DEBE7D-2CFC-4E0C-809C-E3D3D05A6971Q36691255-C240117E-47ED-416E-B19A-FD7DAD819693Q36982335-5808E2E6-186B-4D1D-9229-39502183BCACQ37640117-30633161-B65B-43CB-A572-6A96E64ACBB2Q41193164-138BBD56-5AC5-4170-AE6B-914543EE0412Q47951946-6665662F-D686-4DA3-9BF8-5A2CD57BC085Q50096741-F7D2A894-85E6-476E-A670-4D37DEE8A949Q64137149-A720153E-B017-4FB8-9FC1-761DA46ACB58Q84594926-57C2D8C3-513A-4FFF-9656-886288166ADEQ91735815-56A7182F-7619-4C9B-8175-26344BF5D02CQ92153354-6F63C832-39CF-423C-8465-B3C7347EFD22Q92650703-1442816A-1ECD-4EE3-ADF2-9F400F06A93BQ94675210-3823EF5B-6AF5-4541-AB89-FE0B13663D71Q96131019-16787DE8-8F9C-4A80-8D8A-BC93739621B5Q96583317-6459BB65-F00D-4446-9A4A-98536BD7533C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ehsan Jozaghi
@en
Ehsan Jozaghi
@nl
type
label
Ehsan Jozaghi
@en
Ehsan Jozaghi
@nl
prefLabel
Ehsan Jozaghi
@en
Ehsan Jozaghi
@nl
P31
P496
0000-0002-3555-085X